Bath & Body Works, Inc. (NYSE:BBWI) Position Raised by IFM Investors Pty Ltd

IFM Investors Pty Ltd increased its position in Bath & Body Works, Inc. (NYSE:BBWI) by 3.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 43,663 shares of the company’s stock after acquiring an additional 1,294 shares during the period. IFM Investors Pty Ltd’s holdings in Bath & Body Works were worth $2,184,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Federated Hermes Inc. boosted its position in Bath & Body Works by 17.1% during the 4th quarter. Federated Hermes Inc. now owns 1,612 shares of the company’s stock worth $70,000 after acquiring an additional 235 shares during the period. Comerica Bank raised its stake in shares of Bath & Body Works by 0.9% during the fourth quarter. Comerica Bank now owns 33,091 shares of the company’s stock valued at $1,428,000 after purchasing an additional 280 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Bath & Body Works by 72.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company’s stock valued at $35,000 after buying an additional 337 shares in the last quarter. Commonwealth Equity Services LLC grew its position in Bath & Body Works by 3.3% in the 3rd quarter. Commonwealth Equity Services LLC now owns 11,044 shares of the company’s stock valued at $373,000 after buying an additional 348 shares in the last quarter. Finally, CWM LLC increased its stake in Bath & Body Works by 7.3% during the 4th quarter. CWM LLC now owns 5,167 shares of the company’s stock valued at $223,000 after buying an additional 353 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Price Performance

Bath & Body Works stock traded up $0.44 during mid-day trading on Friday, hitting $46.04. The company’s stock had a trading volume of 1,542,343 shares, compared to its average volume of 2,433,098. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $50.34. The firm’s 50 day moving average is $46.22 and its 200 day moving average is $40.54. The company has a market cap of $10.35 billion, a PE ratio of 11.96, a price-to-earnings-growth ratio of 1.48 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The business had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.84 billion. During the same period last year, the company posted $1.86 earnings per share. The firm’s quarterly revenue was up .8% compared to the same quarter last year. As a group, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 1.74%. Bath & Body Works’s payout ratio is 20.78%.

Insiders Place Their Bets

In other news, insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the sale, the insider now directly owns 45,992 shares in the company, valued at approximately $2,248,548.88. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.19% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on BBWI shares. TD Cowen increased their price objective on shares of Bath & Body Works from $35.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, March 1st. UBS Group boosted their price target on shares of Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Robert W. Baird raised their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $53.00 price objective on shares of Bath & Body Works in a research note on Friday, April 5th. Finally, Barclays downgraded shares of Bath & Body Works from an “overweight” rating to an “equal weight” rating and boosted their target price for the stock from $37.00 to $45.00 in a report on Thursday, January 4th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works has an average rating of “Hold” and a consensus target price of $46.73.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.